Supplemental measles vaccine antibody response among HIV-infected and -uninfected children in Malawi after 1-and 2-dose primary measles vaccination schedules

摘要

Background: The long-term antibody response to measles vaccine (MV) administered at age 6 months with or without subsequent doses is not well documented.